Pantoni L - Search Results

1

The Vascular Impairment of Cognition Classification Consensus Study.

Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group; Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. Skrobot OA, et al. Among authors: pantoni l. Alzheimers Dement. 2017 Jun;13(6):624-633. doi: 10.1016/j.jalz.2016.10.007. Epub 2016 Dec 10. Alzheimers Dement. 2017. PMID: 27960092 Free article.

2

Cooperation and networking on white matter disorders: the European Task Force on Age-Related White Matter Changes.

Erkinjuntti T, Pantoni L, Scheltens P. Erkinjuntti T, et al. Among authors: pantoni l. Dement Geriatr Cogn Disord. 1998 Jul;9 Suppl 1:44-5. doi: 10.1159/000051189. Dement Geriatr Cogn Disord. 1998. PMID: 9716244 No abstract available.

3

Role of white matter lesions in cognitive impairment of vascular origin.

Pantoni L, Leys D, Fazekas F, Longstreth WT Jr, Inzitari D, Wallin A, Filippi M, Scheltens P, Erkinjuntti T, Hachinski V. Pantoni L, et al. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S49-54. Alzheimer Dis Assoc Disord. 1999. PMID: 10609681 Review.

4

Is subcortical vascular dementia a clinical entity for clinical drug trials?

Inzitari D, Erkinjuntti T, Wallin A, del Ser T, Pantoni L. Inzitari D, et al. Among authors: pantoni l. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S66-8. Alzheimer Dis Assoc Disord. 1999. PMID: 10609684 Review.

5

Imaging of static brain lesions in vascular dementia: implications for clinical trials.

Erkinjuntti T, Bowler JV, DeCarli CS, Fazekas F, Inzitari D, O'Brien JT, Pantoni L, Rockwood K, Scheltens P, Wahlund LO, Desmond DW. Erkinjuntti T, et al. Among authors: pantoni l. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S81-90. Alzheimer Dis Assoc Disord. 1999. PMID: 10609686 Review.

6

Nimodipine in subcortical vascular dementia trial.

Rossi R, Inzitari D, Pantoni L, del Ser T, Erkinjuntti T, Wallin A, Bianchi C, Badenas JM, Beneke M. Rossi R, et al. Among authors: pantoni l. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S159-65. Alzheimer Dis Assoc Disord. 1999. PMID: 10609696 Clinical Trial.

7

Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?

Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Desmond DW. Erkinjuntti T, et al. Among authors: pantoni l. Ann N Y Acad Sci. 2000 Apr;903:262-72. doi: 10.1111/j.1749-6632.2000.tb06376.x. Ann N Y Acad Sci. 2000. PMID: 10818515

8

Subcortical vascular dementia as a specific target for clinical trials.

Inzitari D, Erkinjuntti T, Wallin A, Del Ser T, Romanelli M, Pantoni L. Inzitari D, et al. Among authors: pantoni l. Ann N Y Acad Sci. 2000 Apr;903:510-21. doi: 10.1111/j.1749-6632.2000.tb06407.x. Ann N Y Acad Sci. 2000. PMID: 10818546 Review.

9

The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.

Pantoni L, Bianchi C, Beneke M, Inzitari D, Wallin A, Erkinjuntti T. Pantoni L, et al. J Neurol Sci. 2000 Apr 15;175(2):116-23. doi: 10.1016/s0022-510x(00)00301-4. J Neurol Sci. 2000. PMID: 10831772 Clinical Trial.

10

Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.

Pantoni L, Rossi R, Inzitari D, Bianchi C, Beneke M, Erkinjuntti T, Wallin A. Pantoni L, et al. J Neurol Sci. 2000 Apr 15;175(2):124-34. doi: 10.1016/s0022-510x(00)00300-2. J Neurol Sci. 2000. PMID: 10831773 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters